The possibility that a common anesthesia drug may soon be used in the United States to execute death-row inmates is causing problems for European pharmaceutical companies. They worry the European Union may soon impose sanctions.
Read Full Article »
The possibility that a common anesthesia drug may soon be used in the United States to execute death-row inmates is causing problems for European pharmaceutical companies. They worry the European Union may soon impose sanctions.
